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Summary statement 
MacTel affects a well-defined region of the macula, indicating localized susceptibility. Our 
findings indicate that abnormal metabolic handling of luteal pigment and physical changes 
giving rise to increased reflectance are widespread in the macula throughout the natural 
history of the disease, precede other changes and are relevant to early diagnosis.
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ABSTRACT 
 
Purpose: 
Macular Telangiectasia Type 2 (MacTel) is a bilateral, progressive, potentially blinding 
retinal disease characterized by vascular and neurodegenerative signs, including an increased 
parafoveal reflectivity to blue light (BLR). Our aim was to investigate the relationship of this 
sign with other signs of MacTel in multiple imaging modalities. 
 
Methods: 
Participants were selected from the MacTel Study, based on a confirmed diagnosis and the 
availability of images. The extent of signs in BLR, fluorescein  angiographic, optical 
coherence tomographic (OCT) and single- and dual-wavelength autofluorescence (DWAF) 
images were analyzed. 
 
Results: 
A well-defined abnormality of the perifovea is demonstrated by dual wavelength 
autofluorescence and blue light reflectance in early disease. The agreement in area size of the 
abnormalities in DWAF and in BLR images was excellent, for right eyes: ρ=0.917 
(p<0.0001, 95%CI 0.855-0.954, n=46) and for left eyes: ρ=0.952 (p<0.0001, 95%CI 0.916-
0.973, n=49). Other changes are less extensive initially and expand later to occupy that area 
and do not extend beyond it. 
 
Conclusion: 
Our findings indicate that abnormal metabolic handling of luteal pigment and physical 
changes giving rise to increased reflectance are widespread in the macula throughout the 
natural history of the disease, precede other changes and are relevant to early diagnosis. 
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INTRODUCTION 
 
Macular Telangiectasia Type 2 (MacTel) is a bilateral, slowly progressive retinal disease 
of unknown pathogenesis, potentially leading to a loss of central vision.
1
 Previous clinical 
and histopathological data suggest a hereditary cause and a central role for retinal Müller 
cells in the pathogenesis of the disease.
2-4
 
The phenotype of MacTel is limited to the perifoveal region and is characterized by both 
vascular and neurodegenerative changes. Color and red-free fundus photographic signs 
include a loss of retinal transparency, retinal crystals at the level of the internal limiting 
membrane (ILM) and in later disease pigment plaques in the mid-retina. Fundus fluorescein 
angiographic (FFA) signs include dilated, blunted and right-angle veins, dilated deep retinal 
capillaries and hyperfluorescence (early leakage, late staining) but without an increase in 
retinal thickness. In late disease subretinal neovascularization may occur.
5-7
  
More recent imaging modalities have provided valuable insight into previously little or 
unknown characteristics of the phenotype (Figure 1). A loss of retinal transparency is 
considered an early sign in MacTel (driving stage 2 in the severity classification of the 
disease devised by Gass and Blodi
8
), indeed it may be the first detectable manifestation of the 
disease. Reflective imaging using short wavelength light ('blue light reflectance imaging', 
BLR) provides a superior tool for detecting and recording this phenomenon.
9-11
 
Short-wavelength (488nm, blue) autofluorescence imaging may demonstrate increased 
signal in the parafoveal region in early disease, and later decreased autofluorescence 
corresponding to intraretinal perivascular pigment clumps or plaques.
5
 Using dual 
(488+512nm) wavelength autofluorescence (DWAF) imaging,
12-14
 a redistribution of macular 
(luteal) pigment (MP) in a specific pattern can be demonstrated. This pattern typically starts 
with a wedge-shaped depletion of MP just temporal of the foveal center, progressing 
centripetally to involve the foveal center and finally encompasses an oval area centered on 
the fovea, with a band of increased MP density along its boundaries.
15-17
 
In optical coherence tomographic (OCT) images, low-reflecting spaces may be apparent in 
the inner and outer retina, while later in disease progressive atrophy of the outer retina 
occurs. Initially this is characterized by a discontinuity (break) in the line commonly 
attributed to the junctions of the photoreceptor inner and outer segments (or the ellipsoids of 
the inner segments, IS/OS line or ellipsoid zone, EZ),
18-20
 with subsequent structural 
disorganization and apparent 'collapse' of the retinal layers internal to the IS/OS through the 
IS/OS break towards the retinal pigment epithelium (RPE).
18, 21, 22
 The external limiting 
membrane (ELM), a thin hyper-reflective line adjacent to the EZ on OCT, is formed by tight 
junctions between the photoreceptors and Müller cells and its abnormalities may be 
considered a signal of structural changes in either cell type, its morphology in MacTel has 
however not been described. Histopathological studies have shown changes limited to the 
area delineated by BLR and structural changes in Müller cells. 
The aim of the present study in search of clues to the pathogenesis of the disease and of 
signs permitting an early diagnosis, was to investigate the characteristics of abnormal retinal 
reflectivity to short-wavelength light and its relationship with other vascular and 
neurodegenerative clinical signs of MacTel detectable in multiple imaging modalities 
including autofluorescence, fluorescein angiographic, OCT and DWAF imaging. 
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PARTICIPANTS AND METHODS 
 
Participants 
Eyes of participants with a confirmed diagnosis from one site of the MacTel Study, an 
international multicenter prospective natural history observational study of MacTel
5
 were 
chosen for this study. The site was selected on the basis of the availability of a wide range of 
imaging modalities including blue-light reflectance (BLR), autofluorescence (AF), fundus 
fluorescein angiographic (FFA), dual-wavelength autofluorescence (DWAF) and OCT 
images. The study protocol adhered to the tenets of the Declaration of Helsinki and was 
approved by the local institutional review board/ethics committee. Prior to enrolment in the 
study, written, informed consent was obtained from each participant following an explanation 
of the nature of the study.  
 
Imaging 
Images were recording in compliance with a standardised operating protocol by trained 
and certified image acquisition specialists. Blue light reflectance images were acquired using 
either a Heidelberg Retina Angiograph II or a Heidelberg Spectralis SLO system (Heidelberg 
Engineering GmbH, Heidelberg, Germany) using the 'red free' setting (utilizing a 488nm blue 
laser for illumination of the retina). Single-wavelength autofluorescence images were 
acquired using the same excitation wavelength, with a barrier filter for reflected light at 
<520nm. The distribution of macular pigment was recorded by dual-wavelength 
autofluorescence method using a Heidelberg Retina Angiograph Classic scanning laser 
ophthalmoscope system (Heidelberg Engineering GmbH, Heidelberg, Germany). This 
method has been described previously.
12-14
 Briefly, two series of autofluorescence images of 
the fundus were recorded using monochromatic excitation lights of 488nm and 514nm 
wavelength respectively, through a barrier filter for returning light at <560nm. Individual 
images within each sequence were aligned using anatomic (mainly vascular) landmarks and 
averaged to improve the signal-to-noise ratio. A map of relative densities characteristic of 
macular pigment content was calculated from each corresponding pixel pair within the two 
averaged images. In our study 10-16 individual images were averaged at each wavelength 
prior to calculating the macular pigment density maps. Spectral domain OCT volume scans of 
the retina were acquired using Heidelberg Spectralis OCT systems (Heidelberg Engineering 
GmbH, Heidelberg, Germany). Raster volume scans covered a retinal area of at least 15x10 
degrees in size, centered on the fovea, with a maximum B-scan interval of 30 microns. The 
transverse imaging module of the Heidelberg Eye Explorer (HEYEX) software was used for 
creating en face images of the EZ and ELM layers following manual inspection and where 
necessary correction of the automated segmentation of these specific layers provided by 
HEYEX. 
 
Phenotyping 
Images of all modalities (en face OCT of the EZ, of the ELM, early and late FFA, AF, 
DWAF and BLR were aligned to attain exact correspondence primarily using I2K Retina 
version 1.3.8 (DualAlign™ LLC) and collected in multi-layered PSD image files in Adobe 
Photoshop (version CS6, Adobe Systems Inc., San Jose, California, USA). The extent of the 
abnormality in the ELM was delineated based on the points of clear visibility of the ELM and 
both adjacent layers nearest to the retinal abnormality (typically a 'collapse') from to vantage 
points, the standard B-scan perspective and one at 90 to it (in the Y-Z plane) using a 
dedicated 3D imaging software package (Amira v5.3, FEI Inc, Hillsboro, Oregon, USA). 
Orthogonal maps (in the x-y, a.k.a. the 'en face' plane) of the boundary markers were 
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exported to Photoshop and aligned manually to the common geometry of the other imaging 
modalities. All image alignments were inspected and corrected manually as necessary in 
Adobe Photoshop. The extent of abnormalities in each imaging modality was delineated and 
measured (expressed in pixels) manually and their relative areas and locations within the 
plane of the retina were compared.  
Due to their relatively low resolution and grainy quality, duplicates of layers containing 
DWAF images were created and a Gaussian filter was applied to reduce high frequency noise 
prior to delineation of the abnormal area. The distribution pattern of luteal pigment in healthy 
eyes demonstrates a peak at the foveal center and progressively decreases towards a plateau 
value in the peripheral retina. Concentration levels may vary, but the gradient is consistently 
towards the periphery. The boundary of the abnormal area in MacTel eyes was defined as the 
collection of points at which luteal pigment density starts to decline towards the foveal 
center. 
The term 'MacTel area' (introduced by M. Fruttiger, unpublished communications) is 
defined as the region delimited by the outer boundary of increased reflectivity to short-
wavelength light in well established disease (complete ellipse).  
Grading and measurements were performed by one grader masked to the identity and 
clinical data of the patients. To reduce the risk of bias, delineation of lesion boundaries was 
performed in one imaging modality at a time across the whole available sample. Data 
necessary for calibration of true retinal image size (axial length and refractive power of the 
eye) were not available, however most analyses were limited to the relative lateral extent and 
topographic position of lesions within each eye.  
 
Statistical Methods 
The relationships of lesion extent in different imaging modalities was assessed by 
calculating Spearman's rank correlation coefficient. Spearman’s ρ was calculated from 
grading data ranked in order of severity; calculations were based on the differences between 
the ranks of corresponding values of the independent and the dependent variable. The value 
of ρ may range between 1, indicating a perfect correlation and -1, indicating a perfect inverse 
(negative) correlation. A p value of <0.05 was accepted as statistically significant. All 
analyses were conducted using commercially available statistical software (SAS version 9.3; 
SAS Institute, Cary, NC, USA and MedCalc for Windows, version 12.5, MedCalc Software, 
Ostend, Belgium). 
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RESULTS 
 
Full image sets of all imaging modalities were available of 106 eyes of 53 patients (32 
women, 21 men), ranging in age between 30-82 years, (mean=61 years, SD=10.6 years) of a 
quality sufficient for a multimodal analysis. 
In all uncomplicated MacTel cases, the BLR hyper-reflective pattern was confined to an 
oval area centered on the fovea, with the longest axis in the horizontal meridian 
(corresponding approximately to the parafoveal region), always presenting in the temporal 
part and covering varying degrees of the remaining area. The central foveal area 
(corresponding to the foveal pit, and in DWAF images to the central luteal pigment peak) 
appeared in BLR images dark at varying intensities. We measured the approximate horizontal 
and vertical diameters of the outer boundary of the BLR hyperreflective area in well-
established cases (full ellipse), measurements are presented in Table 1. 
Ten eyes of eight patients were excluded from the main analyses and analyzed separately 
due to very extensive lesions not directly attributable to the primary MacTel disease. In one 
eye a large area of subretinal fluid was present, which did not diminish either the BLR, 
DWAF or ELM signals; the visibility of the EZ was however impaired. In two eyes, a highly 
reflective epiretinal membrane (ERM) was present obscuring the boundary of the BLR 
pattern. The ERMs were constricting, causing retinal folds, the DWAF pattern was in both 
cases well detectable, although in one its shape was distorted. In six eyes of four patients a 
subretinal neovascular (NV) complex extending outside the MacTel area was present. 
Whereas small NV lesions do not seem to affect the visibility of either the BLR or DWAF 
signals, as the area size of the NV approaches that of the BLR/DWAF signal, first the BLR 
then the DWAF signals are attenuated or lost. The detectability of the DWAF signal was 
consistently better than that of the BLR signal, except in one case with subretinal hemorrhage 
larger than the parafoveal 'MacTel' area (from a small neovascular lesion), which improved 
the visibility of the BLR signal by providing a dark background, while obfuscating the 
DWAF signal. 
In good quality BLR images, the area of increased reflectivity appeared to be present at 
variable intensities. In 30 eyes (28%) the whole “MacTel” area was evenly hyper-reflective. 
In 55 eyes, (52%) the high level BLR hyper-reflectivity was high temporally and superiorly 
but did not involve the full 'MacTel' area; in these a lower but clearly detectable level of 
increased reflectivity appeared to 'complete' the oval pattern (typically inferiorly or infero-
nasally, see Figure 2 top panel, image A). Images in which this lower level was not visible 
(11 eyes, 10%) or questionable (14 eyes, 13%) were of low quality and the visibility of the 
main pattern was also consistently low. The central foveal area containing in DWAF images 
the central peak of luteal pigment density appeared in BLR images dark at variable levels. 
The detectability of the pattern in BLR images was influenced by several factors, 
including obscuring lids and lashes, tear film anomalies (short break-up time, lipid droplets), 
crystalline lens and vitreous opacities. Obscuring technical factors included defocus, uneven 
field illumination and over-exposure. The pattern brightness appeared to be affected by 
directionality and to some extent by the type of SLO machine used (HRA or Spectralis). 
These phenomena may warrant a further systematic analysis. In this study however, the 
outcome measure was the lateral extent of the BLR hyperreflectivity (and not the intensity of 
the hyperreflectivity) and this was possible to measure in all images.  
We assessed the inter-grader repeatability of measurements of the BLR hyperreflective 
area in well-established disease (complete ellipse) by calculating the intraclass correlation 
coefficient (ICC), investigating absolute agreement between two graders for all 
measurements, in a two-way model (n=18 eyes). The ICC was for single measures 0.9656 
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(95%CI 0.9065 to 0.9872) and for average measures 0.9825 (95%CI 0.9510 to 0.9936). 
The detectability of the DWAF signal was consistently better than that of the BLR signal 
although this did not impede the analysis. 
The concordance in area size of luteal pigment abnormality in DWAF images and the area 
of increased reflectivity to blue light (BLR) was excellent, for right eyes: ρ=0.917 (p<0.0001, 
95%CI 0.855-0.954, n=46) and for left eyes: ρ=0.952 (p<0.0001, 95%CI 0.916-0.973, n=49). 
The mean (BLR) relative area of intersection was in right eyes 88% and in left eyes 87%. 
Removing neovascular cases from the analysis did not significantly affect the correlation. 
The lateral extent of abnormalities in all other imaging modalities was smaller in area and 
located within the area occupied by the BLR/DWAF abnormality. 
Single wavelength (blue) AF images provided a sharp boundary of a hyper-
autofluorescence towards the foveal center (as well as very clear hypo-AF anomalies 
corresponding to brown pigment plaques in the mid-retina), however towards the periphery, 
the boundary was too indistinct to delineate in 28 of a total of 96 cases (29%).  
The correlation between DWAF and AF lesion area was ρ=0.441 (p<0.0091, 95%CI 
0.121-0.678, n=34) for right eyes and ρ=0.554 (p<0.0009, 95%CI 0.253-0.745, n=34) for left 
eyes. The AF abnormality occupied on average 53% of the DWAF abnormality in right eyes 
and 49% in left eyes.  
The correlation between the BLR hyper-reflective area and the area of leakage/staining in 
the late-phase FFA was ρ=0.772 (p<0.0001, 95%CI 0.620-0.868, n=46) for right eyes and 
ρ=0.737 (p<0.0001, 95%CI 0.575-0.843, n=49) for left eyes. The FFA abnormality occupied 
on average 50% of the BLR hyper-reflective area in both right and left eyes.  
The correlation between the BLR hyper-reflective area and the area of a break in the EZ 
(IS/OS layer) was ρ=0.631 (p<0.0001, 95%CI 0.418-0.779, n=46) for right eyes and ρ=0.593 
(p<0.0001, 95%CI 0.374-0.749, n=49) for left eyes. The EZ (IS/OS) break extent was on 
average 15% of the BLR hyper-reflective area in right eyes and 12% in left eyes.  
The correlation in area size and location of the ELM abnormality and the EZ (IS/OS) 
break was very good, ρ=0.989 (p<0.0001, 95%CI 0.980-0.994, n=46) for right eyes and 
ρ=0.978 (p<0.0001, 95%CI 0.961-0.987, n=50) for left eyes. In 32 of 46 right eyes, the area 
of the EZ break was larger than that of the the ELM abnormality (on average by 36% of the 
ELM area, median difference 18%), in 8 eyes it was smaller (on average by 10%, median 
3%), in 6 eyes the two areas were the same. In 32 of 50 left eyes, the area of the EZ 
disruption was larger than that of the ELM lesion (by a mean 40%, median 14%), in 7 eyes it 
was smaller (on average by 5%, median 2%), in 11 eyes the two areas were the same. The 
magnitude of differences was affected by a few outliers (see scatter plot in supplemental 
Figure S1). 
The characteristics and distribution of area measurements are shown in Table 2 and Figure 
3. Agreement between right and left eyes is shown in Table 3. All changes were situated 
within the area delineated by DWAF and blue light reflectance (see supplemental Figure S2). 
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DISCUSSION 
 
Type 2 idiopathic macular telangiectasia - as the name suggests - was long considered a 
primarily vascular disease. However, new imaging modalities including OCT, DWAF and 
BLR imaging have revealed numerous neurodegenerative signs of the disease and contributed 
to a paradigm shift in the hypothesis of its pathogenesis. 
One of these neurodegenerative signs, a 'graying of the foveal area' was mentioned as a 
sign of parafoveal telangiectasia as early as 1978 by Gass et al.
23
 This sign was later 
described as a 'loss of retinal transparency' and alone is the sole criterion of stage 2 in the 
severity classification of the disease devised by Gass and Blodi in 1993.
8
 Charbel-Issa et al. 
demonstrated that this area exhibits an abnormally increased reflectivity to short wavelength 
(488nm) light and can be visualized best using a confocal scanning laser ophthalmoscope.
9, 10
 
Jindal et al. noted that the intensity appeared to fade with continuous light exposure and is 
restored following dark adaptation.
24
 M. Fruttiger noted that all typical signs of MacTel 
appear to be located within an area defined by the outer boundary of increased reflectivity to 
blue light and suggested the term 'MacTel area' as occurred in our cases. 
Our findings show that in the vast majority with early disease a well-defined area is 
apparent on the basis of hyper-reflectivity as seen on blue light reflection and a deficit of 
luteal pigment as recorded by dual wavelength autofluorescence. There was variation of 
intensity of reflectivity in the area as seen on blue light reflectance with the densest being in 
the temporal macula. It is well established that the phenomenon is intensified by dark 
adaptation
24
. Thus in those in which the area was not totally outlined, it is conceivable that it 
would have been complete following a short time in darkness. One limitation of our study is 
that the light exposure (bleaching) status of the eye at the time of BLR imaging was not 
recorded. 
The area of abnormality as seen on single wavelength autofluorescence, and fluorescein 
angiography was limited to the temporal macula in early disease and expands to occupy the 
whole area as defined by blue light reflectance as the disorder progresses.
25
 Deficits in the 
outer retinal lines as seen on OCT appear to occur later, starting temporal to the fovea and 
expands over time to fill the MacTel area. The progression of outer retinal changes becomes 
distorted in late disease by subretinal neovascularization with or without contraction by scar 
tissue in later disease. The progression of these changes appears to be sequentially from 
temporal to the fovea, to nasal, superior and lastly inferior to the fovea. Notable is the 
absence of extension outside the area defined early by blue light.  
These findings are relevant to early diagnosis that is important in the quest for early 
diagnosis when attempting to generate pedigrees as is crucial for genetic studies. Dual 
wavelength autofluorescence or blue light reflectance appear to be equally sensitive. 
However, the former is not widely available such that blue light is the more useful. Important 
is the influence of dark adaptation on this finding
24
 and if a clinician is in doubt as to whether 
or not the abnormality exists, placing the patient in the dark for 10 minutes or so might help 
in decision making. 
These observations are also important to concepts as to the pathogenesis of disease. They 
indicate that abnormal metabolic handling of luteal pigment is widespread in the macula even 
in early disease. It has been shown that Müller cells are involved in the disease process
3, 4 
and 
it is possible that Müller cells are involved in the metabolism of luteal pigments. There is 
evidence that Müller cell are involved in metabolism of other retinoids.
26
 
It is also evident that the retinal region affected by disease is defined early in its progress 
by blue light refection and dual wavelength. Other changes follow to occupy the whole of 
that area but do not expand beyond it. This indicates that a specific susceptibility exits that is 
10 
 
limited to the MacTel area that presumably can be related to a metabolic attribute limited to 
this area. This may be related to the metabolic interdependence between Müller cells and 
photoreceptor cells.
27 
That Müller cell dysfunction is associated with photoreceptor cell loss 
is well illustrated in rodents.
28, 29
 Interestingly these rodents develop outer retinal 
vascularization consistently.
27
  
The only clinically recognized entity that resembles MacTel is seen in Sjögren-Larsson 
syndrome.
25 
Evidence has been sought of genetic similarity between the two disorders but 
none has been found. It is conceivable that certain forms Müller cell dysfunction may cause 
retinal disease that may be confined to the macula, regardless of the underlying cause. 
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FIGURE LEGENDS 
 
Figure 1. Aligned multimodal images of a MacTel eye with very early disease. 
A: 488nm (blue) reflectance image, B: dual-wavelength autofluorescence image (DWAF), C: 
single wavelength (488nm) fundus autofluorescence image, D: infrared image, E and F: early 
and late phase fluorescein angiograms, G: IR image with the en face view of the Ellipsoid 
Zone superimposed, H: IR image with the en face map of the External Limiting Membrane 
(ELM) superimposed. An eye with very early mactel disease from an asymmetrical case, 
demonstrating essentially no sign of mactel and only a few diabetes-related microaneurysms 
in the FFA. The FAF, DWAF images appear essentially normal, demonstrating the peak of 
luteal pigment density at the foveal center, that decreases towards the periphery. The dark 
central area in the EZ map corresponds to the rod-free center of the fovea externa with very 
high packing density of cones, where the EZ signal is normally weaker. The fellow eye (not 
shown) demonstrates all typical signs of MacTel. 
 
 
Figure 2. BLR imaging in MacTel and multimodal correlates. 
Aligned multimodal images of a relatively early case (top panel) and a later-stage MacTel 
eye, bottom panel. A: blue light reflectance images, B: dual wavelength (488+514nm) 
autofluorescence images, C: single (488nm, blue) autofluorescence images, D: early phase 
FFA images, E: late-phase FFA images, F: topographic maps of the EZ (IS/OS layer). The 
small, round, hyper-reflective area close to the fovea in the BLR image in the top panel is an 
artifact due to internal reflections within the lens system of the Spectralis SLO system.  
 
 
Figure 3. Correlation of lesion extent in multimodal images of type 2 MacTel 
 Top row: BLR vs DWAF area in (A) right and (B) in left eyes. Second row: DWAF area vs 
single wavelength blue light AF area,  in right (C) and in left eyes (D). NB: in 28/96 eyes the 
AF lesion was not possible to delineate due to an indistinct peripheral boundary. Third row: 
BLR hyper-reflective area vs late FFA area, in right (E) and in left eyes (F). Bottom row: 
BLR hyper-reflective area vs EZ (IS/OS) break area, in right (G) and in left eyes (H). All data 
shown are expressed in x1000 pixels (proprietary units). 
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Online-only supplemental information: 
 
 
Figure S1. The correlation between EZ and ELM lesion area.  
Scatter plot indicating the relationship of the area size of the abnormality in transverse (en 
face) images of the Ellipsoid Zone (EZ) and the External Limiting Membrane (ELM) in each 
eye in the study (left and right eyes, n=106). The ellipsoid zone is considered a photoreceptor 
signal (emanating from the inner segment ellipsoids or the junctions between the inner and 
outer segments) whereas the ELM has its source in the junctions between the photoreceptors 
and Müller cells. The ELM may be considered a Müller cell signal.  
 
 
Figure S2. The extent of abnormalities in different imaging modalities relative to BLR.  
This image set is the same as the top panel in Figure 2, but with a dotted line marking the 
outer boundary of the hyper-reflective area in BLR imaging superimposed. In MacTel, the 
extent of abnormalities in BLR (A) and DWAF (B) images share this boundary, whereas 
abnormalities in all other imaging modalities (C-H) are located well within it. A: 488nm 
(blue) reflectance (BLR) image, B: dual wavelenght autofluorescence image (DWAF), C: 
single wavelength (488nm) fundus autofluorescence image, D: infrared image, E and F: early 
and late phase fluorescein angiograms, G: IR image with the en face view of the Ellipsoid 
Zone superimposed, H: IR image with the en face map of the External Limiting Membrane 
(ELM) superimposed. 
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